EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
5.51 L
Market Cap
7622.05 CR
LTQ@LTP
10@168.15
ATP
164.47
Var Margin
21.01 %
Circuit Range
134.44-201.64
Delivery %
34.37 %
Value
9.06 CR
ASM/GSM
No
Market Lot
1
Summary
At 2 Apr, 2026 | 15:59, Marksans Pharma share price stands at ₹168.15, showing a 0.11% 0.07 for the day. The stock’s intraday movement has stayed between ₹160.60 and ₹169.17, while on a 52-week basis it has fluctuated from ₹155.00 to ₹270.70.
In terms of trading activity, Marksans Pharma has recorded a volume of 550727 shares, with a market capitalisation of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹16447, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10,16815. The stock operates within a circuit range of ₹134.44-201.64, with a Value of ₹9.06 CR. The Delivery Percentage for the day is 34.37%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
21.13
P/B Ratio
2.72
Div. Yield
0.48
Sector P/E
59.77
Sector P/B
3.14
Sec. Div. Yield
0.6
Marksans Pharma Resistance and Support
Pivot 166.78
Resistance
First Resistance
172.74
Second Resistance
177.44
Third Resistance
183.4
Support
First Support
162.08
Second Support
156.12
Third Support
151.42
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Limited
Marksans Pharma received USFDA final approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx). This approval signifies a market entry for a product bioequivalent to Pfizer's Tessalon Capsules, addressing respiratory conditions like cough and bronchitis.
Apr 01 2026 12:04:00
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma received USFDA final approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx). This product is bioequivalent and therapeutically equivalent to Pfizer Inc.'s Tessalon Capsules, expanding the company's respiratory segment.
Apr 01 2026 12:04:00
Read More
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
Marksans Pharma Similar Stocks
Park Medi World Ltd.
197.19
-0.84 (0.42%)
Viyash Scientific Ltd.
191.76
-1.17 (0.61%)
Healthcare Global Enterprises Ltd.
527.70
-7.45 (1.39%)
Sanofi India Ltd.
3265.00
2.60 (0.08%)
Akums Drugs & Pharmaceuticals Ltd.
499.05
2.60 (0.52%)
Shilpa Medicare Ltd.
388.90
14.20 (3.79%)
Sudeep Pharma Ltd.
615.10
1.10 (0.18%)
Yatharth Hospital & Trauma Care Services Ltd.
671.55
4.90 (0.74%)
Blue Jet Healthcare Ltd.
357.35
6.35 (1.81%)
Thyrocare Technologies Ltd.
366.00
4.00 (1.10%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 168.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 21.13. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 2.72. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 59.77 & 3.14 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 7622.05 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
